The beta-amyloid protein of alzheimer's disease: Communication breakdown by modifying the neuronal cytoskeleton

International Journal of Alzheimer's Disease

Volumn 2013, Issue , 2013, Pages

  Mokhtar, Sara H ^a   Bakhuraysah, Maha M ^a   Cram, David S ^a   Petratos, Steven ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; CYCLIN DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3BETA; KINESIN; PHOSPHATASE; RHO KINASE; TAU PROTEIN; TUBULIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; BRAIN NERVE CELL; CELL COMMUNICATION; CYTOSKELETON; HUMAN; MICROTUBULE; MOLECULAR PATHOLOGY; MOLECULE; NERVE CELL MEMBRANE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 84893650355     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2013/910502     Document Type: Article

References (146)

1. Kozlowski H., Luczkowski M., Remelli M., Valensin D., Copper, zinc and iron in neurodegenerative diseases (Alzheimer's, Parkinson's and prion diseases). Coordination Chemistry Reviews 2012 256 19-20 2129 2141 2-s2.0-84859480059 10.1016/j.ccr.2012.03.013
2. Kumar P., Pradhan K., Karunya R., Ambasta R. K., Querfurth H. W., Cross-functional E3 ligases Parkin and C-terminus Hsp70-interacting protein in neurodegenerative disorders. Journal of Neurochemistry 2012 120 3 350 370 2-s2.0-84855695865 10.1111/j.1471-4159.2011.07588.x
3. Liu R., Wang J., Protein phosphatase 2A in Alzheimer's disease. Pathophysiology 2009 16 4 273 277 2-s2.0-69249221553 10.1016/j.pathophys.2009. 02.008
4. Crews L., Rockenstein E., Masliah E., APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis. Brain Structure and Function 2010 214 2-3 111 126 2-s2.0-77950461116 10.1007/s00429-009-0232-6
5. Przedborski S., Vila M., Jackson-Lewis V., Neurodegeneration: what is it and where are we? Journal of Clinical Investigation 2003 111 1 3 10 2-s2.0-0037248298 10.1172/JCI200317522
6. Chan K. C., Cai K. X., Su H. X., Early detection of neurodegeneration in brain ischemia by manganese-enhanced MRI. Proceedings of the IEEE Conference on Engineering in Medicine and Biology Society 2008 3884 3887
7. Selkoe D., Mandelkow E., Holtzman D., Deciphering Alzheimer disease. Cold Spring Harbor Laboratory Press 2012 2 1 a011460 10.1101/cshperspect.a011460
8. Morimatsu M., Hirai S., Muramatsu A., Yoshikawa M., Senile degenerative brain lesions and dementia. Journal of the American Geriatrics Society 1975 23 9 390 406 2-s2.0-0016827568
9. Sisodia S. S., Koo E. H., Beyreuther K., Unterbeck A., Price D. L., Evidence that β -amyloid protein in Alzheimer's disease is not derived by normal processing. Science 1990 248 4954 492 495 2-s2.0-0025373508
10. Kirschner D. A., Abraham C., Selkoe D. J., X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross- β conformation. Proceedings of the National Academy of Sciences of the United States of America 1986 83 2 503 507 2-s2.0-0022547855
11. Esch F. S., Keim P. S., Beattie E. C., Blacher R. W., Culwell A. R., Oltersdorf T., McClure D., Ward P. J., Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 1990 248 4959 1122 1124 2-s2.0-0025295039
12. Williamson T. G., Mok S. S., Henry A., Cappai R., Lander A. D., Nurcombe V., Beyreuther K., Masters C. L., Small D. H., Secreted glypican binds to the amyloid precursor protein of Alzheimer's disease (APP) and inhibits APP-induced neurite outgrowth. Journal of Biological Chemistry 1996 271 49 31215 31221 2-s2.0-10544230644 10.1074/jbc.271.49.31215
13. Small D. H., Williamson T., Reed G., Clarris H., Beyreuther K., Masters C. L., Nurcombe V., The role of heparan sulfate proteoglycans in the pathogenesis of Alzheimer's disease. Annals of the New York Academy of Sciences 1996 777 316 321 2-s2.0-0029921091
14. Small D. H., Nurcombe V., Reed G., Clarris H., Moir R., Beyreuther K., Masters C. L., A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. Journal of Neuroscience 1994 14 4 2117 2127 2-s2.0-0028213567
15. Wei W. Q., Ferreira A., Miller C., Koo E. H., Selkoe D. J., Cell-surface β -amyloid precursor protein stimulates neurite outgrowth of hippocampal neurons in an isoform-dependent manner. Journal of Neuroscience 1995 15 3 2157 2167 2-s2.0-0029257190
16. Ohsawa I., Hirose Y., Ishiguro M., Imai Y., Ishiura S., Kohsaka S., Expression, purification, and neurotrophic activity of amyloid precursor protein-secreted forms produced by yeast. Biochemical and Biophysical Research Communications 1995 213 1 52 58 2-s2.0-0029098519 10.1006/bbrc.1995.2097
17. Milward E. A., Papadopoulos R., Fuller S. J., Moir R. D., Small D., Beyreuther K., Masters C. L., The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron 1992 9 1 129 137 2-s2.0-0026663993 10.1016/0896-6273(92)90228- 6
18. Jin L. W., Ninomiya H., Roch J., Schubert D., Masliah E., Otero D. A. C., Saitoh T., Peptides containing the RERMS sequence of amyloid β /A4 protein precursor bind cell surface and promote neurite extension. Journal of Neuroscience 1994 14 9 5461 5470 2-s2.0-0028136865
19. Breen K. C., Bruce M., Anderton B. H., Beta amyloid precursor protein mediates neuronal cell-cell and cell-surface adhesion. Journal of Neuroscience Research 1991 28 1 90 100 2-s2.0-0025965521 10.1002/jnr.490280109
20. Allinquant B., Hantraye P., Mailleux P., Moya K., Bouillot C., Prochiantz A., Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro. Journal of Cell Biology 1995 128 5 919 927 2-s2.0-0028963635 10.1083/jcb.128.5.919
21. Nguyen T. V. V., Galvan V., Huang W., Banwait S., Tang H., Zhang J., Bredesen D. E., Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664. Journal of Neurochemistry 2008 104 4 1065 1080 2-s2.0-38449120482 10.1111/j.1471-4159.2007. 05031.x
22. Sinha S., Lieberburg I., Cellular mechanisms of β -amyloid production and secretion. Proceedings of the National Academy of Sciences of the United States of America 1999 96 20 11049 11053 2-s2.0-0033613129 10.1073/pnas.96.20.11049
23. Anderson J. P., Chen Y., Kim K. S., Robakis N. K., An alternative secretase cleavage produces soluble Alzheimer amyloid precursor protein containing a potentially amyloidogenic sequence. Journal of Neurochemistry 1992 59 6 2328 2331 2-s2.0-0026545684
24. Snyder E. M., Nong Y., Almeida C. G., Paul S., Moran T., Choi E. Y., Nairn A. C., Salter M. W., Lombroso P. J., Gouras G. K., Greengard P., Regulation of NMDA receptor trafficking by amyloid- β Nature Neuroscience 2005 8 8 1051 1058 2-s2.0-23044445669 10.1038/nn1503
25. Mucke L., Masliah E., Yu G., Mallory M., Rockenstein E. M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., McConlogue L., High-level neuronal expression of A β (1-42) in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. Journal of Neuroscience 2000 20 11 4050 4058 2-s2.0-0034213718
26. Muresan V., Varvel N. H., Lamb B. T., Muresan Z., The cleavage products of amyloid- β precursor protein are sorted to distinct carrier vesicles that are independently transported within neurites. Journal of Neuroscience 2009 29 11 3565 3578 2-s2.0-63849105306 10.1523/JNEUROSCI.2558-08.2009
27. Ahlgren S., Li G. L., Olsson Y., Accumulation of β -amyloid precursor protein and ubiquitin in axons after spinal cord trauma in humans: immunohistochemical observations on autopsy material. Acta Neuropathologica 1996 92 1 48 55 2-s2.0-0029984013
28. Cras P., Kawai M., Lowery D., Gonzalez-DeWhitt P., Greenberg B., Perry G., Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proceedings of the National Academy of Sciences of the United States of America 1991 88 17 7552 7556 2-s2.0-0025773835
29. Sisodia S. S., Tanzi R. E., Alzheimer's Disease. Advances in Genetics and Cellular Biology 2007 New York, NY, USA Springer Science+Business Media LLC
30. Chakravarthy B., Gaudet C., Ménard M., Atkinson T., Brown L., Laferla F. M., Armato U., Whitfield J., Amyloid- β peptides stimulate the expression of the p75NTR neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice. Journal of Alzheimer's Disease 2010 19 3 915 925 2-s2.0-77149138009 10.3233/JAD-2010-1288
31. Hensley K., Venkova K., Christov A., Gunning W., Park J., Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications. Molecular Neurobiology 2011 43 3 180 191 2-s2.0-79958282898 10.1007/s12035-011-8166-4
32. Donahue J. E., Flaherty S. L., Johanson C. E., Duncan J. A. III, Silverberg G. D., Miller M. C., Tavares R., Yang W., Wu Q., Sabo E., Hovanesian V., Stopa E. G., RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathologica 2006 112 4 405 415 2-s2.0-33749157416 10.1007/s00401-006- 0115-3
33. Shankar G. M., Li S., Mehta T. H., Garcia-Munoz A., Shepardson N. E., Smith I., Brett F. M., Farrell M. A., Rowan M. J., Lemere C. A., Regan C. M., Walsh D. M., Sabatini B. L., Selkoe D. J., Amyloid- β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nature Medicine 2008 14 8 837 842 2-s2.0-49149124343 10.1038/nm1782
34. Chiarini A., Pra I. D., Whitfield J. F., Armato U., The killing of neurons by β -amyloid peptides, prions, and pro-inflammatory cytokines. Italian Journal of Anatomy and Embryology 2006 111 4 221 246 2-s2.0-33847772938
35. Behl C., Davis J. B., Lesley R., Schubert D., Hydrogen peroxide mediates amyloid β protein toxicity. Cell 1994 77 6 817 827 2-s2.0-0028233494 10.1016/0092-8674(94)90131-7
36. Muresan Z., Muresan V., Neuritic deposits of amyloid- β peptide in a subpopulation of central nervous system-derived neuronal cells. Molecular and Cellular Biology 2006 26 13 4982 4997 2-s2.0-33745452465 10.1128/MCB.00371-06
37. Jack C. R. Jr., Knopman D. S., Jagust W. J., Shaw L. M., Aisen P. S., Weiner M. W., Petersen R. C., Trojanowski J. Q., Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. The Lancet Neurology 2010 9 1 119 128 2-s2.0-72049130805 10.1016/S1474-4422(09)70299-6
38. Rodrigues E., Weissmiller A., Golstein L., Enhanced β -secretase processing alters APP axonal transport and leads to axonal defects. Human Molecular Genetics 2012 21 21 4587 4601 10.1093/hmg/dds297
39. Devanand D. P., Schupf N., Stern Y., Parsey R., Pelton G. H., Mehta P., Mayeux R., Plasma A β and PET PiB binding are inversely related in mild cognitive impairment. Neurology 2011 77 2 125 131 2-s2.0-80051495814 10.1212/WNL.0b013e318224afb7
40. Um J. W., Nygaard H. B., Heiss J. K., Alzheimer amyloid- β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nature Neuroscience 2012 15 9 1227 1235 10.1038/nn.3178
41. Hirokawa N., Shiomura Y., Okabe S., Tau proteins: the molecular structure and mode of binding on microtubules. Journal of Cell Biology 1988 107 4 1449 1459 2-s2.0-0024094998
42. Scott C. W., Klika A. B., Lo M. M. S., Norris T. E., Caputo C. B., Tau protein induces bundling of microtubules in vitro: comparison of different tau isoforms and a tau protein fragment. Journal of Neuroscience Research 1992 33 1 19 29 2-s2.0-0026666829
43. Whiteman I. T., Gervasio O. L., Cullen K. M., Guillemin G. J., Jeong E. V., Witting P. K., Antao S. T., Minamide L. S., Bamburg J. R., Goldsbury C., Activated actin-depolymerizing factor/cofilin sequesters phosphorylated microtubule-associated protein during the assembly of Alzheimer-like neuritic cytoskeletal striations. Journal of Neuroscience 2009 29 41 12994 13005 2-s2.0-70350435136 10.1523/JNEUROSCI.3531-09.2009
44. Li L., Liu Z., Liu J., Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A. Neurobiology of Disease 2013 54 320 328 10.1016/j.nbd.2013.01.002
45. Arendt T., Holzer M., Fruth R., Brückner M. K., Gärtner U., Phosphorylation of tau, a β -formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A. Neurobiology of Aging 1998 19 1 3 13 2-s2.0-0031596660 10.1016/S0197-4580(98)00003-7
46. Ittner L. M., Fath T., Ke Y. D., Bi M., Van Eersel J., Li K. M., Gunning P., Götz J., Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia. Proceedings of the National Academy of Sciences of the United States of America 2008 105 41 15997 16002 2-s2.0-57349172663 10.1073/pnas.0808084105
47. Terry R. D., The cytoskeleton in Alzheimer disease. Journal of Neural Transmission 1998 53 141 145 2-s2.0-0031596264
48. Velasco M. E., Smith M. A., Siedlak S. L., Nunomura A., Perry G., Striation is the characteristic neuritic abnormality in Alzheimer disease. Brain Research 1998 813 2 329 333 2-s2.0-0032495144 10.1016/S0006-8993(98)01034-8
49. Martin L., Latypova X., Terro F., Post-translational modifications of tau protein: implications for Alzheimer's disease. Neurochemistry International 2011 58 4 458 471 2-s2.0-79952105548 10.1016/j.neuint.2010.12.023
50. Bulic B., Pickhardt M., Mandelkow E., Mandelkow E., Tau protein and tau aggregation inhibitors. Neuropharmacology 2010 59 4-5 276 289 2-s2.0-77955927938 10.1016/j.neuropharm.2010.01.016
51. Shelton S. B., Johnson G. V. W., Cyclin-dependent kinase-5 in neurodegeneration. Journal of Neurochemistry 2004 88 6 1313 1326 2-s2.0-1642269125
52. Iqbal K., Alonso A. D. C., Grundke-Iqbal I., Cytosolic abnormally hyperphosphorylated tau but not paired helical filaments sequester normal MAPs and inhibit microtubule assembly. Journal of Alzheimer's Disease 2008 14 4 365 370 2-s2.0-49149105134
53. Maccioni R. B., Farías G., Morales I., Navarrete L., The revitalized tau hypothesis on Alzheimer's disease. Archives of Medical Research 2010 41 3 226 231 2-s2.0-77953499350 10.1016/j.arcmed.2010.03.007
54. Amadoro G., Corsetti V., Ciotti M. T., Florenzano F., Capsoni S., Amato G., Calissano P., Endogenous A β causes cell death via early tau hyperphosphorylation. Neurobiology of Aging 2011 32 6 969 990 2-s2.0-79955950475 10.1016/j.neurobiolaging.2009.06.005
55. Lavados M., Guillón M., Mujica M. C., Rojo L. E., Fuentes P., Maccioni R. B., Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron. Journal of Alzheimer's Disease 2008 13 2 225 232 2-s2.0-44849129360
56. Zambrano C. A., Egaña J. T., Núñez M. T., Maccioni R. B., González-Billault C., Oxidative stress promotes τ dephosphorylation in neuronal cells: the roles of cdk5 and PP1. Free Radical Biology and Medicine 2004 36 11 1393 1402 2-s2.0-2342466091 10.1016/j. freeradbiomed.2004.03.007
57. Neumann K. F., Rojo L., Navarrete L. P., Farías G., Reyes P., Maccioni R. B., Insulin resistance and Alzheimer's disease: molecular links amp; clinical implications. Current Alzheimer Research 2008 5 5 438 447 2-s2.0-53549097355 10.2174/156720508785908919
58. Roberson E. D., Scearce-Levie K., Palop J. J., Yan F., Cheng I. H., Wu T., Gerstein H., Yu G., Mucke L., Reducing endogenous tau ameliorates amyloid β -induced deficits in an Alzheimer's disease mouse model. Science 2007 316 5825 750 754 2-s2.0-34248181511 10.1126/science.1141736
59. Nakagawa O., Fujisawa K., Ishizaki T., Saito Y., Nakao K., Narumiya S., ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Letters 1996 392 2 189 193 2-s2.0-0030603119 10.1016/0014-5793(96)00811-3
60. Sordella R., Jiang W., Chen G., Curto M., Settleman J., Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis. Cell 2003 113 2 147 158 2-s2.0-0037453716 10.1016/S0092-8674(03)00271-X
61. Zhao L., Ma Q., Calon F., Harris-White M. E., Yang F., Lim G. P., Morihara T., Ubeda O. J., Ambegaokar S., Hansen J. E., Weisbart R. H., Teter B., Frautschy S. A., Cole G. M., Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nature Neuroscience 2006 9 2 234 242 2-s2.0-31544476561 10.1038/nn1630
62. Gorovoy M., Niu J., Bernard O., Profirovic J., Minshall R., Neamu R., Voyno-Yasenetskaya T., LIM kinase 1 coordinates microtubule stability and actin polymerization in human endothelial cells. Journal of Biological Chemistry 2005 280 28 26533 26542 2-s2.0-22544470912 10.1074/jbc.M502921200
63. Daniels R. H., Hall P. S., Bokoch G. M., Membrane targeting of p21-activated kinase 1 (PAK1) induces neurite outgrowth from PC12 cells. EMBO Journal 1998 17 3 754 764 2-s2.0-0032472918 10.1093/emboj/17.3.754
64. Goeckeler Z. M., Masaracchia R. A., Zeng Q., Chew T., Gallagher P., Wysolmerski R. B., Phosphorylation of myosin light chain kinase by p21-activated kinase PAK2. Journal of Biological Chemistry 2000 275 24 18366 18374 2-s2.0-0034674408 10.1074/jbc.M001339200
65. Chew T., Masaracchia R. A., Goeckeler Z. M., Wysolmerski R. B., Phosphorylation of non-muscle myosin II regulatory light chain by p21-activated kinase (γ -PAK). Journal of Muscle Research and Cell Motility 1998 19 8 839 854 2-s2.0-0032438538 10.1023/A:1005417926585
66. Gallo G., Myosin II activity is required for severing-induced axon retraction in vitro. Experimental Neurology 2004 189 1 112 121 2-s2.0-3543149555 10.1016/j.expneurol.2004.05.019
67. Arimura N., Inagaki N., Chihara K., Ménager C., Nakamura N., Amano M., Iwamatsu A., Goshima Y., Kaibuchi K., Phosphorylation of collapsin response mediator protein-2 by Rho-kinase: evidence for two separate signaling pathways for growth cone collapse. Journal of Biological Chemistry 2000 275 31 23973 23980 2-s2.0-0034604710 10.1074/jbc.M001032200
68. Niederöst B., Oertle T., Fritsche J., McKinney R. A., Bandtlow C. E., Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. Journal of Neuroscience 2002 22 23 10368 10376 2-s2.0-0036895744
69. Heredia L., Helguera P., De Olmos S., Kedikian G., Vigo F. S., LaFerla F., Staufenbiel M., De Olmos J., Busciglio J., Cáceres A., Lorenzo A., Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid β -induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimer's disease. Journal of Neuroscience 2006 26 24 6533 6542 2-s2.0-33745780575 10.1523/JNEUROSCI.5567-05.2006
70. Gylys K. H., Fein J. A., Yang F., Wiley D. J., Miller C. A., Cole G. M., Snaptic changes in alzheimer's disease: increased amyloid- β and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence. American Journal of Pathology 2004 165 5 1809 1817 2-s2.0-7244223228
71. Ma Q. L., Yang F., Calon F., Ubeda O. J., Hansen J. E., Weisbart R. H., Beech W., Frautschy S. A., Cole G. M., p21-activated kinase-aberrant activation and translocation in Alzheimer disease pathogenesis. Journal of Biological Chemistry 2008 283 20 14132 14143 2-s2.0-46649100113 10.1074/jbc.M708034200
72. Salminen A., Suuronen T., Kaarniranta K., ROCK, PAK, and Toll of synapses in Alzheimer's disease. Biochemical and Biophysical Research Communications 2008 371 4 587 590 2-s2.0-44149122564 10.1016/j.bbrc.2008.04.148
73. Leuchtenberger S., Kummer M. P., Kukar T., Czirr E., Teusch N., Sagi S. A., Berdeaux R., Pietrzik C. U., Ladd T. B., Golde T. E., Koo E. H., Weggen S., Inhibitors of Rho-kinase modulate amyloid- β (A β) secretion but lack selectivity for A β 42. Journal of Neurochemistry 2006 96 2 355 365 2-s2.0-33644875726 10.1111/j.1471-4159.2005.03553.x
74. Del Pozo M. A., Alderson N. B., Kiosses W. B., Chiang H., Anderson R. G. W., Schwartz M. A., Integrins regulate rac targeting by internalization of membrane domains. Science 2004 303 5659 839 842 2-s2.0-0842331441 10.1126/science.1092571
75. Guirland C., Suzuki S., Kojima M., Lu B., Zheng J. Q., Lipid rafts mediate chemotropic guidance of nerve growth cones. Neuron 2004 42 1 51 62 2-s2.0-1842557804 10.1016/S0896-6273(04)00157-6
76. Cole A. R., Noble W., Aalten L. V., Plattner F., Meimaridou R., Hogan D., Taylor M., LaFrancois J., Gunn-Moore F., Verkhratsky A., Oddo S., Laferla F., Giese K. P., Dineley K. T., Duff K., Richardson J. C., Yan S. D., Hanger D. P., Allan S. M., Sutherland C., Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression. Journal of Neurochemistry 2007 103 3 1132 1144 2-s2.0-35248821113 10.1111/j.1471-4159.2007.04829.x
77. Uchida Y., Ohshima T., Sasaki Y., Suzuki H., Yanai S., Yamashita N., Nakamura F., Takei K., Ihara Y., Mikoshiba K., Kolattukudy P., Honnorat J., Goshima Y., Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3 β phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Genes to Cells 2005 10 2 165 179 2-s2.0-20044370438 10.1111/j.1365-2443.2005.00827.x
78. Petratos S., Li Q., George A. J., Hou X., Kerr M. L., Unabia S. E., Hatzinisiriou I., Maksel D., Aguilar M., Small D. H., The β -amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Brain 2008 131 1 90 108 2-s2.0-37549010213 10.1093/brain/awm260
79. Proctor C. J., Gray D. A., GSK3 and p53-is there a link in Alzheimer's disease? Molecular Neurodegeneration 2010 5 1 7 2-s2.0-77649324578 10.1186/1750-1326-5-7
80. Kim W.-Y., Snider W. D., Functions of GSK-3 signaling in development of the nervous system. Frontiers in Molecular Neuroscience 2011 4 44 10.3389/fnmol.2011.00044
81. Cole A. R., Knebel A., Morrice N. A., Robertson L. A., Irving A. J., Connolly C. N., Sutherland C., GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons. Journal of Biological Chemistry 2004 279 48 50176 50180 2-s2.0-9644276856 10.1074/jbc.C400412200
82. Frame S., Cohen P., GSK3 takes centre stage more than 20 years after its discovery. Biochemical Journal 2001 359 1 1 16 2-s2.0-0035477020 10.1042/0264-6021:3590001
83. Salcedo-Tello P., Ortiz-Matamoros A., Arias C., GSK3 function in the brain during development, neuronal plasticity, and neurodegeneration. International Journal of Alzheimer's Disease 2011 2011 12 2-s2.0-79959223383 10.4061/2011/189728 189728
84. Qian W., Shi J., Yin X., Iqbal K., Grundke-Iqbal I., Gong C., Liu F., PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3 β Journal of Alzheimer's Disease 2010 19 4 1221 1229 2-s2.0-77950366745 10.3233/JAD-2010-1317
85. Ryan K. A., Pimplikar S. W., Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. Journal of Cell Biology 2005 171 2 327 335 2-s2.0-27544442991 10.1083/jcb.200505078
86. Cole A. R., Soutar M. P. M., Rembutsu M., Van Aalten L., Hastie C. J., Mclauchlan H., Peggie M., Balastik M., Kun P. L., Sutherland C., Relative resistance of Cdk5-phosphorylated CRMP2 to dephosphorylation. Journal of Biological Chemistry 2008 283 26 18227 18237 2-s2.0-49649119782 10.1074/jbc.M801645200
87. Piedrahita D., Hernández I., López-Tobón A., Fedorov D., Obara B., Manjunath B. S., Boudreau R. L., Davidson B., LaFerla F., Gallego-Gómez J. C., Kosik K. S., Cardona-Gómez G. P., Silencing of CDK5 reduces neurofibrillary tangles in transgenic Alzheimer's mice. Journal of Neuroscience 2010 30 42 13966 13976 2-s2.0-77958608578 10.1523/JNEUROSCI. 3637-10.2010
88. Peterson D. W., Ando D. M., Taketa D. A., Zhou H., Dahlquist F. W., Lew J., No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro. Proceedings of the National Academy of Sciences of the United States of America 2010 107 7 2884 2889 2-s2.0-77649250664 10.1073/pnas.0912718107
89. Chae T., Kwon Y. T., Bronson R., Dikkes P., En L., Tsai L., Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 1997 18 1 29 42 2-s2.0-0031018336 10.1016/S0896-6273(01)80044-1
90. Ohshima T., Ward J. M., Huh C., Longenecker G., Veeranna V., Pant H. C., Brady R. O., Martin L. J., Kulkarni A. B., Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proceedings of the National Academy of Sciences of the United States of America 1996 93 20 11173 11178 2-s2.0-0029768093 10.1073/pnas.93.20.11173
91. Cheung Z. H., Ip N. Y., Cdk5: a multifaceted kinase in neurodegenerative diseases. Trends in Cell Biology 2012 22 3 169 175 2-s2.0-84857781607 10.1016/j.tcb.2011.11.003
92. Wen Y., Planel E., Herman M., Figueroa H. Y., Wang L., Liu L., Lau L., Wai H. Y., Duff K. E., Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 β mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. Journal of Neuroscience 2008 28 10 2624 2632 2-s2.0-40449087334 10.1523/JNEUROSCI.5245- 07.2008
93. Hill J. J., Callaghan D. A., Ding W., Kelly J. F., Chakravarthy B. R., Identification of okadaic acid-induced phosphorylation events by a mass spectrometry approach. Biochemical and Biophysical Research Communications 2006 342 3 791 799 2-s2.0-33644626215 10.1016/j.bbrc.2006.02.029
94. Braithwaite S. P., Stock J. B., Lombroso P. J., Nairn A. C., Protein phosphatases and Alzheimer's Disease. Progress in Molecular Biology and Translational Science 2012 106 343 379 2-s2.0-84857227455 10.1016/B978-0-12- 396456-4.00012-2
95. Martin L., Latypova X., Wilson C. M., Magnaudeix A., Perrin M. L., Terro F., Tau protein phosphatases in Alzheimer's disease: the leading role of PP2A. Ageing Research Reviews 2013 12 1 39 49 10.1016/j.arr.2012.06.008
96. Liu F., Grundke-Iqbal I., Iqbal K., Gong C., Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. European Journal of Neuroscience 2005 22 8 1942 1950 2-s2.0-27644478606 10.1111/j.1460-9568.2005.04391.x
97. Xu Y., Chen Y., Zhang P., Jeffrey P. D., Shi Y., Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated tau dephosphorylation. Molecular Cell 2008 31 6 873 885 2-s2.0-52049100425 10.1016/j.molcel.2008.08.006
98. Kins S., Crameri A., Evans D. R. H., Hemmings B. A., Nitsch R. M., Götz J., Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice. Journal of Biological Chemistry 2001 276 41 38193 38200 2-s2.0-0035851175
99. Tanimukai H., Grundke-Iqbal I., Iqbal K., Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. American Journal of Pathology 2005 166 6 1761 1771 2-s2.0-19544362550
100. Sontag E., Luangpirom A., Hladik C., Mudrak I., Ogris E., Speciale S., White C. L. III, Altered expression levels of the protein phosphatase 2A AB α C enzyme are associated with Alzheimer disease pathology. Journal of Neuropathology and Experimental Neurology 2004 63 4 287 301 2-s2.0-1842510667
101. Gong C. X., Lidsky T., Wegiel J., Zuck L., Grundke-Iqbal I., Iqbal K., Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. Journal of Biological Chemistry 2000 275 8 5535 5544 2-s2.0-0034088846 10.1074/jbc.275.8.5535
102. Ando K., Iijima K., Elliott J. I., Kirino Y., Suzuki T., Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of β -amyloid. Journal of Biological Chemistry 2001 276 43 40353 40361 2-s2.0-0035955712
103. Iijima K., Ando K., Takeda S., Satoh Y., Seki T., Itohara S., Greengard P., Kirino Y., Nairn A. C., Suzuki T., Neuron-specific phosphorylation of Alzheimer's β -amyloid precursor protein by cyclin-dependent kinase 5. Journal of Neurochemistry 2000 75 3 1085 1091 2-s2.0-0033836219 10.1046/j.1471-4159.2000.0751085.x
104. Liu R., Zhou X.-W., Tanila H., Bjorkdahl C., Wang J.-Z., Guan Z.-Z., Cao Y., Gustafsson J.-Å., Winblad B., Pei J.-J., Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology: in focus. Journal of Cellular and Molecular Medicine 2008 12 1 241 257 2-s2.0-41149086325 10.1111/j.1582-4934.2008.00249.x
105. Sontag E., Nunbhakdi-Craig V., Sontag J., Diaz-Arrastia R., Ogris E., Dayal S., Lentz S. R., Arning E., Bottiglieri T., Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation. Journal of Neuroscience 2007 27 11 2751 2759 2-s2.0-33947328858 10.1523/JNEUROSCI.3316-06.2007
106. Da Cruz Silva E. E. F., Da Cruz Silva E. O. A., Zaia C. T., Greengard P., Inhibition of protein phosphatase 1 stimulates secretion of Alzheimer amyloid precursor protein. Molecular Medicine 1995 1 5 535 541 2-s2.0-0029328289
107. Holzer M., Brückner M. K., Beck M., Bigl V., Arendt T., Modulation of APP processing and secretion by okadaic acid in primary guinea pig neurons. Journal of Neural Transmission 2000 107 4 451 461 2-s2.0-0034125535
108. De Baere I., Derua R., Janssens V., Van Hoof C., Waelkens E., Merlevede W., Goris J., Purification of porcine brain protein phosphatase 2A leucine carboxyl methyltransferase and cloning of the human homologue. Biochemistry 1999 38 50 16539 16547 2-s2.0-0033554835 10.1021/bi991646a
109. Sontag J. M., Nunbhakdi-Craig V., Montgomery L., Arning E., Bottiglieri T., Sontag E., Folate deficiency induces in vitro and mouse brain region-specific downregulation of leucine carboxyl methyltransferase-1 and protein phosphatase 2A B α subunit expression that correlate with enhanced tau phosphorylation. Journal of Neuroscience 2008 28 45 11477 11487 2-s2.0-58149213742 10.1523/JNEUROSCI.2816-08.2008
110. Vogelsberg-Ragaglia V., Schuck T., Trojanowski J. Q., Lee V. M.-Y., PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Experimental Neurology 2001 168 2 402 412 2-s2.0-0035075793 10.1006/exnr.2001. 7630
111. Wang L. H., Strittmatter S. M., Brain CRMP forms heterotetramers similar to liver dihydropyrimidinase. Journal of Neurochemistry 1997 69 6 2261 2269 2-s2.0-0030724396
112. Hamajima N., Matsuda K., Sakata S., Tamaki N., Sasaki M., Nonaka M., A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution. Gene 1996 180 1-2 157 163 2-s2.0-0030597343 10.1016/S0378-1119(96)00445-3
113. Wang L. H., Strittmatter S. M., A family of rat CRMP genes is differentially expressed in the nervous system. Journal of Neuroscience 1996 16 19 6197 6207 2-s2.0-0029813784
114. Inagaki N., Chihara K., Arimura N., Ménager C., Kawano Y., Matsuo N., Nishimura T., Amano M., Kaibuchi K., CRMP-2 induces axons in cultured hippocampal neurons. Nature Neuroscience 2001 4 8 781 782 2-s2.0-0034934624 10.1038/90476
115. Morita T., Sobuě K., Specification of neuronal polarity regulated by local translation of CRMP2 and tau via the mTOR-p70S6K pathway. Journal of Biological Chemistry 2009 284 40 27734 27745 2-s2.0-70350455151 10.1074/jbc.M109.008177
116. Arimura N., Menager C., Fukata Y., Kaibuchi K., Role of CRMP-2 in neuronal polarity. Journal of Neurobiology 2004 58 1 34 47 2-s2.0-0346120150 10.1002/neu.10269
117. Arimura N., Ménager C., Kawano Y., Yoshimura T., Kawabata S., Hattori A., Fukata Y., Amano M., Goshima Y., Inagaki M., Morone N., Usukura J., Kaibuchi K., Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones. Molecular and Cellular Biology 2005 25 22 9973 9984 2-s2.0-27644447928 10.1128/MCB.25.22.9973-9984.2005
118. Yoshimura T., Kawano Y., Arimura N., Kawabata S., Kikuchi A., Kaibuchi K., GSK-3 β regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 2005 120 1 137 149 2-s2.0-11844297771 10.1016/j.cell.2004.11.012
119. Soutar M. P. M., Thornhill P., Cole A. R., Sutherland C., Increased CRMP2 phosphorylation is observed in Alzheimer's disease; does this tell us anything about disease development? Current Alzheimer Research 2009 6 3 269 278 2-s2.0-67149093780 10.2174/156720509788486572
120. Asai H., Ikezu S., Varnum M., Ikezu T., Phosphorylation of collapsin response mediator protein-2 and axonal degeneration in transgenic mice expressing a familial Alzheimer's disease mutant of APP and tau-tubulin kinase 1. Alzheimer's & Dementia 2012 8 4 649 650
121. Yoneda A., Morgan-Fisher M., Wait R., Couchman J. R., Wewer U. M., A collapsin response mediator protein 2 isoform controls myosin II-mediated cell migration and matrix assembly by trapping ROCK II. Molecular and Cellular Biology 2012 32 10 1788 1804 10.1128/MCB.06235-11
122. Kimura T., Arimura N., Fukata Y., Watanabe H., Iwamatsu A., Kaibuchi K., Tubulin and CRMP-2 complex is transported via Kinesin-1. Journal of Neurochemistry 2005 93 6 1371 1382 2-s2.0-20744459425 10.1111/j.1471-4159.2005. 03063.x
123. Kawano Y., Yoshimura T., Tsuboi D., Kawabata S., Kaneko-Kawano T., Shirataki H., Takenawa T., Kaibuchi K., CRMP-2 is involved in kinesin-1-dependent transport of the Sra-1/WAVE1 complex and axon formation.
124. Nishimura T., Fukata Y., Kato K., Yamaguchi T., Matsuura Y., Kamiguchi H., Kaibuchi K., CRMP-2 regulates polarized Numb-mediated endocytosis for axon growth. Nature Cell Biology 2003 5 9 819 826 2-s2.0-0041689545 10.1038/ncb1039
125. Tan M., Ma S., Huang Q., Hu K., Song B., Li M., GSK-3 α / β -mediated phosphorylation of CRMP-2 regulates activity-dependent dendritic growth. Journal of Neurochemistry 2013 125 5 685 697 10.1111/jnc.12230
126. Fukata Y., Itoh T. J., Kimura T., Ménager C., Nishimura T., Shiromizu T., Watanabe H., Inagaki N., Iwamatsu A., Hotani H., Kaibuchi K., CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nature Cell Biology 2002 4 8 583 591 2-s2.0-0036048640 10.1038/ncb825
127. Reis G. F., Yang G., Szpankowski L., Weaver C., Shah S. B., Robinson J. T., Hays T. S., Danuser G., Goldstein L. S. B., Molecular motor function in axonal transport in vivo probed by genetic and computational analysis in Drosophila. Molecular Biology of the Cell 2012 23 9 1700 1714 2-s2.0-84860372407 10.1091/mbc.E11-11-0938
128. Falzone T. L., Stokin G. B., Imaging amyloid precursor protein in vivo: an axonal transport assay. Methods in Molecular Biology 2012 846 295 303 2-s2.0-84859873131 10.1007/978-1-61779-536-7-25
129. Iqbal K., Grundke-Iqbal I., Alzheimer abnormally phosphorylated tau is more hyperphosphorylated than the fetal tau and causes the disruption of microtubules. Neurobiology of Aging 1995 16 3 375 379 2-s2.0-0029008731 10.1016/0197-4580(95)00033-B
130. Potter H., Borysov S., Ari C., A β inhibits specific kinesin motors involved in both mitosis and neuronal function; potential implications for neurogenesis and neuroplasticity in Alzheimer's disease and Down syndrome. Alzheimer's & Dementia 2011 7 4 24
131. Brunden K. R., Yao Y., Potuzak J. S., Ferrer N. I., Ballatore C., James M. J., Hogan A. L., Trojanowski J. Q., Smith A. B. III, Lee V. M.-Y., The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies. Pharmacological Research 2011 63 4 341 351 2-s2.0-79951814364 10.1016/j.phrs.2010.12.002
132. Ye X., Tai W., Zhang D., The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits. Neurobiology of Aging 2012 33 6 1122.e1 1122.e10 2-s2.0-84859513533 10.1016/j.neurobiolaging.2011.11.004
133. Mao P., Reddy P. H., Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics. Biochimica et Biophysica Acta 2011 1812 11 1359 1370 2-s2.0-80052538857 10.1016/j.bbadis.2011.08.005
134. Goldstein L. S. B., Larry R. S., Axonal transport and Alzheimer's diseasein. Encyclopedia of Neuroscience 2009 Oxford, UK Academic Press 1189 1194
135. Mitsuyama F., Futatsugi Y., Okuya M., Kawase T., Karagiozov K., Kato Y., Kanno T., Sano H., Nagao S., Koide T., Stimulation-dependent intraspinal microtubules and synaptic failure in Alzheimer's disease: a review. International Journal of Alzheimer's Disease 2012 2012 7 2-s2.0-84859752563 10.1155/2012/519682 519682
136. Paula-Barbosa M., Tavares M. A., Cadete-Leite A., A quantitative study of frontal cortex dendritic microtubules in patients with Alzheimer's disease. Brain Research 1987 417 1 139 142 2-s2.0-0023513805
137. Fiala J. C., Mechanisms of amyloid plaque pathogenesis. Acta Neuropathologica 2007 114 6 551 571 2-s2.0-36248971777 10.1007/s00401-007-0284-8
138. Adalbert R., Nogradi A., Babetto E., Janeckova L., Walker S. A., Kerschensteiner M., Misgeld T., Coleman M. P., Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. Brain 2009 132 2 402 416 2-s2.0-60149092294 10.1093/brain/awn312
139. Goldstein L. S. B., Kinesin molecular motors: transport pathways, receptors, and human disease. Proceedings of the National Academy of Sciences of the United States of America 2001 98 13 6999 7003 2-s2.0-0035912767 10.1073/pnas.111145298
140. Dhaenens C., Van Brussel E., Schraen-Maschke S., Pasquier F., Delacourte A., Sablonnire B., Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease. Neuroscience Letters 2004 368 3 290 292 2-s2.0-4544250975 10.1016/j.neulet.2004.07.040
141. Szpankowski L., Encalada S. E., Goldstein L. S. B., Subpixel colocalization reveals amyloid precursor protein-dependent kinesin-1 and dynein association with axonal vesicles. Proceedings of the National Academy of Sciences of the United States of America 2012 109 22 8582 8587 10.1073/pnas.1120510109
142. Stokin G. B., Lillo C., Falzone T. L., Brusch R. G., Rockenstein E., Mount S. L., Raman R., Davies P., Masliah E., Williams D. S., Goldstein L. S. B., Axonopathy and transport deficits early in the pathogenesis of Alzheimer's diseases. Science 2005 307 5713 1282 1288 2-s2.0-20044385920 10.1126/science.1105681
143. Kamal A., Stokin G. B., Yang Z., Xia C., Goldstein L. S. B., Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 2000 28 2 449 459 2-s2.0-0033636136
144. Traina G., Federighi G., Brunelli M., Up-regulation of kinesin light-chain 1 gene expression by acetyl-l-carnitine: therapeutic possibility in Alzheimer's disease. Neurochemistry International 2008 53 6-8 244 247 2-s2.0-56349128625 10.1016/j.neuint.2008.08.001
145. Falzone T. L., Gunawardena S., McCleary D., Reis G. F., Goldstein L. S. B., Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies. Human Molecular Genetics 2010 19 22 4399 4408 2-s2.0-77958459087 10.1093/hmg/ddq363 ddq363
146. Quach T. T., Duchemin A., Rogemond V., Aguera M., Honnorat J., Belin M., Kolattukudy P. E., Involvement of collapsin response mediator proteins in the neurite extension induced by neurotrophins in dorsal root ganglion neurons. Molecular and Cellular Neuroscience 2004 25 3 433 443 2-s2.0-1642292542 10.1016/j.mcn.2003.11.006